SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cyberoptics Corp. – ‘10-Q’ for 6/30/20 – ‘EX-31.1’

On:  Friday, 8/7/20, at 10:24am ET   ·   For:  6/30/20   ·   Accession #:  897101-20-631   ·   File #:  0-16577

Previous ‘10-Q’:  ‘10-Q’ on 5/8/20 for 3/31/20   ·   Next:  ‘10-Q’ on 11/10/20 for 9/30/20   ·   Latest:  ‘10-Q’ on 8/11/22 for 6/30/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/07/20  Cyberoptics Corp.                 10-Q        6/30/20   84:9.1M                                   American Fin’l P… Inc/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.01M 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 9: EX-32       Certification -- §906 - SOA'02                      HTML     26K 
11: R1          Document And Entity Information                     HTML     76K 
12: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    105K 
13: R3          Condensed Consoldiated Balance Sheets (Unaudited)   HTML     40K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     65K 
                (Unaudited)                                                      
15: R5          Condensed Consolidated Statements of Comprehensive  HTML     49K 
                Income (Loss) (Unaudited)                                        
16: R6          Condensed Consolidated Statements of Cash Flows     HTML     94K 
                (Unaudited)                                                      
17: R7          Interim Reporting                                   HTML     29K 
18: R8          Covid-19 Pandemic                                   HTML     38K 
19: R9          Recent Accounting Developments                      HTML     27K 
20: R10         Revenue Recognition                                 HTML     79K 
21: R11         Marketable Securities                               HTML    127K 
22: R12         Fair Value Measurements                             HTML     86K 
23: R13         Share-Based Compensation                            HTML     62K 
24: R14         Changes In Stockholders' Equity                     HTML    161K 
25: R15         Other Financial Statement Data                      HTML     76K 
26: R16         Intangible Assets                                   HTML     73K 
27: R17         Revenue Concentrations, Significant Customers And   HTML     69K 
                Geographic Areas                                                 
28: R18         Net Income Per Share                                HTML     76K 
29: R19         Other Comprehensive Income (Loss)                   HTML     64K 
30: R20         Income Taxes                                        HTML     40K 
31: R21         Operating Leases                                    HTML     36K 
32: R22         Share Repurchases                                   HTML     25K 
33: R23         Contingencies                                       HTML     27K 
34: R24         Recent Accounting Developments (Policies)           HTML     26K 
35: R25         Revenue Recognition (Tables)                        HTML     79K 
36: R26         Marketable Securities (Tables)                      HTML    122K 
37: R27         Fair Value Measurements (Tables)                    HTML     78K 
38: R28         Share-Based Compensation (Tables)                   HTML     51K 
39: R29         Changes In Stockholders' Equity (Tables)            HTML    161K 
40: R30         Other Financial Statement Data (Tables)             HTML     80K 
41: R31         Intangible Assets (Tables)                          HTML     70K 
42: R32         Revenue Concentrations, Significant Customers And   HTML     70K 
                Geographic Areas (Tables)                                        
43: R33         Net Income Per Share (Tables)                       HTML     71K 
44: R34         Other Comprehensive Income (Loss) (Tables)          HTML     65K 
45: R35         Operating Leases (Tables)                           HTML     29K 
46: R36         Covid-19 Pandemic (Narrative) (Details)             HTML     28K 
47: R37         Revenue Recognition (Summary Of Revenue             HTML     34K 
                Performance Obligations) (Details)                               
48: R38         Revenue Recognition (Schedule of contract assets    HTML     29K 
                and contract liabilities) (Details)                              
49: R39         Revenue Recognition (Narrative) (Details)           HTML     33K 
50: R40         Revenue Recognition (Summary of the amounts         HTML     29K 
                reclassified from beginning contract liabilities                 
                to revenue) (Details)                                            
51: R41         Marketable Securities (Schedule Of Marketable       HTML     56K 
                Securities) (Details)                                            
52: R42         Marketable Securities (Schedule Of Unrealized Loss  HTML     40K 
                Position) (Details)                                              
53: R43         Marketable Securities (Narrative) (Details)         HTML     36K 
54: R44         Marketable Securities (Schedule Of Marketable       HTML     27K 
                Securities Classified As Cash Equivalents)                       
                (Details)                                                        
55: R45         Fair Value Measurements (Narrative) (Details)       HTML     27K 
56: R46         Fair Value Measurements (Fair Value Measurements    HTML     56K 
                For Marketable Securities And Foreign Exchange                   
                Forward Contracts) (Details)                                     
57: R47         Share-Based Compensation (Narrative) (Details)      HTML    120K 
58: R48         Share-Based Compensation (Schedule Of Stock Option  HTML     54K 
                Activity) (Details)                                              
59: R49         Share-Based Compensation (Schedule Of Non-Vested    HTML     47K 
                Restricted Stock Activity) (Details)                             
60: R50         Changes In Stockholders' Equity (Schedule of        HTML     88K 
                Changes in Stockholders' Equity) (Details)                       
61: R51         Other Financial Statement Data (Schedule Of         HTML     34K 
                Inventories) (Details)                                           
62: R52         Other Financial Statement Data (Schedule Of         HTML     36K 
                Accrued Expenses) (Details)                                      
63: R53         Other Financial Statement Data (Narrative)          HTML     34K 
                (Details)                                                        
64: R54         Other Financial Statement Data (Schedule Of         HTML     39K 
                Changes In Estimated Warranty Liability) (Details)               
65: R55         Other Financial Statement Data (Schedule Of         HTML     34K 
                Changes In Deferred Warranty Revenue) (Details)                  
66: R56         Intangible Assets (Schedule Of Intangible Assets)   HTML     38K 
                (Details)                                                        
67: R57         Intangible Assets (Schedule Of Amortization         HTML     34K 
                Expense For Intangible Assets) (Details)                         
68: R58         Intangible Assets (Narrative) (Details)             HTML     36K 
69: R59         Revenue Concentrations, Significant Customers, and  HTML     33K 
                Geographic Areas (Summary Of Revenue By Product                  
                Line) (Details)                                                  
70: R60         Revenue Concentrations, Significant Customers And   HTML     37K 
                Geographic Areas (Narrative) (Details)                           
71: R61         Revenue Concentrations, Significant Customers And   HTML     39K 
                Geographic Areas (Schedule Of Sales By Geographic                
                Area) (Details)                                                  
72: R62         Net Income Per Share (Schedule of Net Income per    HTML     45K 
                Basic and Diluted Shares) (Details)                              
73: R63         Net Income Per Share (Narrative) (Details)          HTML     25K 
74: R64         Other Comprehensive Income (Loss) (Narrative)       HTML     25K 
                (Details)                                                        
75: R65         Other Comprehensive Income (Loss) (The Effect Of    HTML     50K 
                The Reclassifications From Other Comprehensive                   
                Loss To Earnings) (Details)                                      
76: R66         Other Comprehensive Income (Loss) (Schedule Of      HTML     35K 
                Accumulated Other Comprehensive Loss) (Details)                  
77: R67         Income Taxes (Details)                              HTML     33K 
78: R68         Operating Leases (Narrative) (Details)              HTML     36K 
79: R69         Operating Leases (Schedule of the future            HTML     43K 
                maturities of lease liabilities) (Details)                       
80: R70         Share Repurchases (Narrative) (Details)             HTML     27K 
82: XML         IDEA XML File -- Filing Summary                      XML    159K 
10: XML         XBRL Instance -- cybe-20200630_htm                   XML   2.35M 
81: EXCEL       IDEA Workbook of Financial Reports                  XLSX     87K 
 4: EX-101.CAL  XBRL Calculations -- cybe-20200630_cal               XML    293K 
 2: EX-101.DEF  XBRL Definitions -- cybe-20200630_def                XML    765K 
 5: EX-101.LAB  XBRL Labels -- cybe-20200630_lab                     XML   2.40M 
 3: EX-101.PRE  XBRL Presentations -- cybe-20200630_pre              XML   1.23M 
 6: EX-101.SCH  XBRL Schema -- cybe-20200630                         XSD    180K 
83: JSON        XBRL Instance as JSON Data -- MetaLinks              391±   601K 
84: ZIP         XBRL Zipped Folder -- 0000897101-20-000631-xbrl      Zip    240K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



EXHIBIT 31.1
I, Subodh Kulkarni, certify that:
1.          I have reviewed this Quarterly Report on Form 10-Q of CyberOptics Corporation.
2.          Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.          Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.          The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.          The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Signature
 
 
Title: President and Chief Executive Officer





Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/7/20None on these Dates
For Period end:6/30/20
 List all Filings 
Top
Filing Submission 0000897101-20-000631   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 6:59:00.1am ET